Care for Critically Ill Patients with Incontinence-Associated Dermatitis: A Case Study
Article Sidebar
Main Article Content
Abstract
Incontinence-associated dermatitis (IAD) is a leading cause of pressure injury and negatively impacts the achievement of key performance indicators in critical care units. This article aims to present: 1) risk factors for the development of IAD, 2) the mechanisms of IAD formation, 3) risk assessment tools and severity assessment tools for IAD 4) prevention and management of IAD based on severity levels. Results of care showing the integration of IAD prevention and management cycle framework along with evidence-based practices in critically ill patients with IAD that effectively reduce IAD severity and promote IAD healing.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวชิรสารการพยาบาลถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรง ซึ่งกองบรรณาธิการไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใด ๆ ทั้งสิ้น
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวชิรสารการพยาบาล ถือเป็นลิขสิทธิ์ของวชิรสารการพยาบาล หากบุคคลใดหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใด ๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากวชิรสารการพยาบาลก่อนเท่านั้น
References
United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects 2022: Summary of Results. UN DESA/POP/.
Kayser SA, Koloms K, Murray A, Khawar W, Gray M. Incontinence and incontinence-associated dermatitis in acute care: A retrospective analysis of total cost of care and patient outcomes from the Premier Healthcare Database. JWOCN. 2021;48(6):545-52. doi: 10.1097/WON.0000000000000818.
Uppanisakorn S, Somma T, Vattanaprasan P, Boonyarat J. Prevention and treatment of incontinence-associated dermatitis (IAD) in critical patients treated in the intensive care unit of a medical ward. Thai J Nurs Coun. 2015;30(2):86-100. (in Thai)
Beeckman D. Incontinence-associated dermatitis (IAD) and pressure ulcers: an overview. In: Romanelli M, Clark M, Gefen A, Ciprandi G, editors. Science and practice of pressure ulcer management. 2nd ed. London, UK: Springer; 2018: 89–101.
Deprez J, Ohde N, Eilegård Wallin A, Bååth C, Hommel A, Hultin L, et al. Prognostic factors for the development of incontinence-associated dermatitis (IAD): A systematic review. Int Wound J. 2024;21(7). doi: 10.1111/iwj.14962.
da Silva Meirelles LC, da Rocha BP, Wammes AL, dos Santos DM, da Silva DM, de Souza LM. Incidence of incontinence-associated dermatitis among clinical inpatients. Rev Enferm UERJ. 2020;28: e51323. doi: 10.12957/ reuerj.2020.51323.
Wang G, Wang X, Wang H, Wang L, Li W. Risk factors for incontinence-associated dermatitis in critically ill patients with incontinence: A systematic review and meta-analysis. JWOCN. 2024;51(4):313-323. doi: 10.1097/WON.0000000000001090.
Cui Y, Zhou Y, Liu C, Mao Z, Zhou F. Interpretable machine learning models for predicting the incidence of antibiotic-associated diarrhea in elderly ICU patients. BMC Geriatrics. 2024;24(1): 458. doi: 10.1186/s12877-024-05028-8.
Banharak S, Panpanit L, Subindee S, Narongsanoi P, Sanun-Aur P, Kulwong W, et al. Prevention and care for incontinence-associated dermatitis among older adults: A systematic review. J Multidiscip Healthc. 2021; 2983-3004. doi: 10.2147/JMDH.S329672.
Nix DH. Validity and reliability of the Perineal Assessment Tool. Ostomy Wound Manage. 2002;48(2):43-46.
Junkin J. TargetingIncontinence – Associated Dermatitis: A Leading Risk Factor for Pressure Ulcers.In The 3rd Congress of the World Union of Wound Healing Societies; 4-8 June 2008.
Simimand S, Banharak S, editors. Measuring translation and psychometric testing of the Perineal Assessment Tool (PAT) and Incontinence-Associated Dermatitis Intervention Tool (IADIT) among patients in semi-intensive care units: A pilot study. Science, Technology, and Social Sciences Procedia. 2023;2023(3): NCCR03.
Wei HH, Huang C-L, Huang W-P, Chen H-C. Development of an incontinence-associated dermatitis prevention bundle using an evidence-based framework. World Counc Enterostomal Ther J. 2020;40(3):37-42. doi: 10.33235/wcet.40.3.37-42.
Beeckman D, Campbell J, Campbell K, Denise Chimentão D, Domansky R, Gray M, et al. Incontinence-associated dermatitis: Moving prevention forward. Wounds Int [Internet]. 2015 [cited 2024 Aug 15]. Available from www.woundsinternational.com.
Phungsiri P. The effect of utilizing work instruction for incontinence-associated dermatitis in high-risk patients. Reg 11 Med J. 2016;30(1):59-67. (in Thai)
Gunasegaran N, Ang SY, Ng YZ, Lee NES, Agus N, Lee CW, et al. The effectiveness of a hydrocolloid crusting method versus standard care in the treatment of incontinence-associated dermatitis among adult patients in an acute care setting: A randomized controlled trial. J Tissue Viability. 2023;32(2):171-178. doi: 10.1016/j.jtv.2023.01.007.
Beele H, Smet S, Van Damme N, Beeckman D. Incontinence-associated dermatitis: Pathogenesis, contributing factors, prevention, and management options. Drugs Aging. 2018;35:1-10. doi: 10.1007/s40266-017-0507-1.
LeBlanc K, Forest-Lalande L, Rajhathy E, Parsons L, Hill M, Kuhnke JL, et al. Best practice recommendations for the prevention and management of moisture-associated skin damage. Wound Care Canada [Internet]. 2020 [cited 2024 Aug 15]. Available from: www.woundscanada.ca/docman/public.
